Hem › Icke-småcellig lungcancer › Illinois › Cicero
Kliniska studier för Icke-småcellig lungcancer i Cicero, IL
24 studier för Icke-småcellig lungcancer söker deltagare vid platser i och runt Cicero (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
RekryterarFas 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · 10 mi bort
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekryterarFas 3
- Edward Hines Jr VA Hospital, Hines · 4 mi bort
- Advocate Christ Medical Center, Oak Lawn · 9 mi bort
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekryterarFas 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi bort
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekryterarFas 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi bort
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RekryterarFas 3
- Advocate Christ Medical Center, Oak Lawn · 9 mi bort
- Hope and Healing Cancer Services, Hinsdale · 10 mi bort
- Endeavor Health, Elmhurst · 10 mi bort
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
RekryterarFas 2
- Hope and Healing Clinical Research, Hinsdale · 10 mi bort
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
RekryterarFas 3
- Research Site, Hinsdale · 10 mi bort
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
RekryterarFas 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi bort
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
RekryterarFas 3
- Research Site, Hinsdale · 10 mi bort
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekryterarFas 2/3
- Loyola University Medical Center, Maywood · 5 mi bort
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
RekryterarFas 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi bort
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekryterarFas 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi bort
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
RekryterarFas 3
- Research Site, Hinsdale · 10 mi bort
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RekryterarFas 3
- Research Site, Hinsdale · 10 mi bort
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
RekryterarFas 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi bort
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RekryterarFas 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · 10 mi bort
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekryterarFas 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi bort
- Edward Hines Jr VA Hospital, Hines · 4 mi bort
- Loyola University Medical Center, Maywood · 5 mi bort
- och 2 fler
MYLUNG Consortium Part 3: Observational Study
RekryterarObservationsstudie
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi bort
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekryterarFas 2
- Edward Hines Jr VA Hospital, Hines · 4 mi bort
- Loyola University Medical Center, Maywood · 5 mi bort
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi bort
- och 3 fler
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekryterarFas 2/3
- Loyola University Medical Center, Maywood · 5 mi bort
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi bort
- Advocate Christ Medical Center, Oak Lawn · 9 mi bort
- och 2 fler
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekryterarFas 2
- Edward Hines Jr VA Hospital, Hines · 4 mi bort
- Loyola University Medical Center, Maywood · 5 mi bort
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi bort
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekryterarObservationsstudie
- Advocate Christ Medical Center, Oak Lawn · 9 mi bort
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mi bort
- Advocate High Tech Medical Park, Palos Heights · 12 mi bort
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Rekryterar
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4 mi bort
GEMINI-NSCLC: NSCLC Biomarker Study
RekryterarObservationsstudie
- Hope and Healing Cancer Services, Hinsdale · 10 mi bort
Icke-småcellig lungcancer-studier i andra städer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andra studier i Cicero
- Lungcancer17 studier
- Prostatacancer14 studier
- Cancer (alla typer)13 studier
- Bröstcancer11 studier
- Akut myeloid leukemi11 studier
- Kolorektal cancer10 studier
- Blåscancer8 studier
- Melanom7 studier
- Hjärt-kärlsjukdom7 studier
- Metastaserande cancer7 studier
- Multipelt myelom6 studier
- Burkitts lymfom6 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.